Dexrazoxane Safety Questions, Dexrazoxane Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about Dexrazoxane side effects. Our extensive database of Dexrazoxane adverse events and Dexrazoxane warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Dexrazoxane
Dexrazoxane Safety Reports
Total Dexrazoxane reports: 2.Dexrazoxane FDA safety alerts: No.
Reported hospitalizations: 2.
Take Dexrazoxane Side Effects Survey or Share Your Dexrazoxane Story.
Reported Dexrazoxane Side Effects: pancreatic enzymes increased, hypoxia, hepatic enzyme increased, haemoptysis, retinoic acid syndrome, renal failure acute, pneumonia, interstitial lung disease, hepatic function abnormal, gamma-glutamyltransferase increased, aspartate aminotransferase increased.
Dexrazoxane Usage.
Dexrazoxane Side Effects Report #5245522-9
Health Professional from FRANCE reported DEXRAZOXANE problem on Feb 12, 2007. Female patient, 60 years of age, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia, nausea, vomiting and was treated with DEXRAZOXANE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, haemoptysis, hepatic enzyme increased, hepatic function abnormal, hypoxia, interstitial lung disease, pancreatic enzymes increased. DEXRAZOXANE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, PRIMPERAN, ZOFRAN, VESANOID, RANITIDINE. Patient was hospitalized. Patient recovered.
Dexrazoxane Side Effects Report #5177380-5
DEXRAZOXANE problem was reported by a Health Professional from FRANCE on Nov 27, 2006. Female patient, 60 years of age, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia, nausea and was treated with DEXRAZOXANE. After drug was administered, patient experienced the following problems/side effects: haemoptysis, hepatic enzyme increased, hypoxia, pancreatic enzymes increased, pneumonia, renal failure acute, retinoic acid syndrome. DEXRAZOXANE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, PRIMPERAN, ZOFRAN, VESANOID. Patient was hospitalized. Patient recovered.